Metabolic syndrome (MetS) in Lebanese patients with schizophrenia receiving atypical antipsychotic drugs

被引：6
|
作者：
Khalil, R. Bou [1 ,2 ]
Rohayem, J. [3 ]
Abou Said, N. [4 ]
El Chammay, R. [2 ]
Haddad, R. [2 ]
Richa, S. [2 ]
机构：
[1] Psychiat Hosp Cross, POB 60096, Jalledib, Lebanon
[2] St Joseph Univ, Beirut, Lebanon
[3] Lebanon Psychiat Hosp, Cross Jalledib, Lebanon
[4] Ain Wazein Hosp, Ain Wazein, Lebanon
来源：
ASIAN JOURNAL OF PSYCHIATRY | 2013年 / 6卷 / 01期
关键词：
D O I：
10.1016/j.ajp.2012.08.005
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：88 / 89
页数：2
相关论文
共 50 条
  • [21] Atypical antipsychotic drugs in childhood onset schizophrenia
    Mozes, T
    Tyano, S
    EUROPEAN PSYCHIATRY, 2002, 17 : 74S - 75S
  • [22] Metabolic syndrome in antipsychotic naive patients diagnosed with schizophrenia
    Grover, Sandeep
    Nebhinani, Naresh
    Chakrabarti, Subho
    Parakh, Preeti
    Ghormode, Deepak
    EARLY INTERVENTION IN PSYCHIATRY, 2012, 6 (03) : 326 - 331
  • [23] The Relationship Between Metabolic Syndrome (mets) and Neurocognitive Functioning in Patients with Schizophrenia
    Lindenmayer, Jean-Pierre
    Khan, Anzalee
    Praveen, Rajalakshmi
    Thanju, Amod
    Hoffman, Lisa
    Valdez, Gladys
    Cherath, Lata
    Wance, Deborah
    BIOLOGICAL PSYCHIATRY, 2012, 71 (08) : 87S - 87S
  • [24] Minimizing Cardiovascular Adverse Effects of Atypical Antipsychotic Drugs in Patients with Schizophrenia
    Khasawneh, Fadi T.
    Shankar, Gollapudi S.
    CARDIOLOGY RESEARCH AND PRACTICE, 2014, 2014
  • [25] Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
    Jeon, Sang Won
    Kim, Yong-Ku
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (10)
  • [26] Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs
    Hasnain, Mehrul
    Fredrickson, Sonja K.
    Vieweg, W. Victor R.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (06) : 715 - 721
  • [27] Atypical Antipsychotic Exposure May Not Differentiate Metabolic Phenotypes of Patients with Schizophrenia
    Ward, Kristen M.
    Yeoman, Larisa
    McHugh, Cora
    Kraal, A. Zarina
    Flowers, Stephanie A.
    Rothberg, Amy E.
    Karnovsky, Alla
    Das, Arun K.
    Ellingrod, Vicki L.
    Stringer, Kathleen A.
    PHARMACOTHERAPY, 2018, 38 (06): : 638 - 650
  • [28] Early prediction of clinical response in schizophrenia patients receiving the atypical antipsychotic zotepine
    Lin, Ching-Hua
    Chou, Li-Shiu
    Lin, Chieh-Hsin
    Hsu, Chih-Yao
    Chen, Yong-Shing
    Lane, Hsien-Yuan
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (10) : 1522 - 1527
  • [29] Therapeutic Efficacy of Atypical Antipsychotic Drugs by Targeting Multiple Stress-Related Metabolic Pathways in Schizophrenia Patients
    Cai, HuaLin
    Yao, Jeffrey
    Zhou, Xiang
    BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S444 - S444
  • [30] Metabolic Hormones in Schizophrenia Patients with Antipsychotic-Induced Metabolic Syndrome
    Boiko, Anastasiia S.
    Mednova, Irina A.
    Kornetova, Elena G.
    Goncharova, Anastasiia A.
    Semke, Arkadiy, V
    Bokhan, Nikolay A.
    Ivanova, Svetlana A.
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (10):
12345